Ken‐ichi Okada

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Manabu Kawai · 4 shared papers, 2014–2024 · strength 0.57
   • Paper Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic… DOI 10.1002/jhbp.1436↗
   • Paper Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuv… DOI 10.1016/j.pan.2023.10.016↗
   • Paper Advances in immunotherapy for pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.944↗
2. Yuji Kitahata · 3 shared papers, 2014–2024 · strength 0.40
   • Paper Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic… DOI 10.1002/jhbp.1436↗
   • Paper Advances in immunotherapy for pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.944↗
   • Paper Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.109↗
3. Atsushi Shimizu · 2 shared papers, 2014–2024 · strength 0.25
   • Paper Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic… DOI 10.1002/jhbp.1436↗
   • Paper Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.109↗
4. Hideki Motobayashi · 1 shared paper, 2024 · strength 0.21
   • Paper Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic… DOI 10.1002/jhbp.1436↗
5. Tomohiro Yoshimura · 1 shared paper, 2024 · strength 0.21
   • Paper Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic… DOI 10.1002/jhbp.1436↗
6. Hiroki Yamaue · 2 shared papers, 2014–2021 · strength 0.19
   • Paper Advances in immunotherapy for pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.944↗
   • Paper Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.109↗
7. Motoki Miyazawa · 2 shared papers, 2014–2021 · strength 0.19
   • Paper Advances in immunotherapy for pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.944↗
   • Paper Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.109↗
8. Seiko Hirono · 2 shared papers, 2014–2021 · strength 0.19
   • Paper Advances in immunotherapy for pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.944↗
   • Paper Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.109↗
9. Yuki Kawaji · 1 shared paper, 2023 · strength 0.17
   • Paper Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuv… DOI 10.1016/j.pan.2023.10.016↗
10. Keiichi Hatamaru · 1 shared paper, 2023 · strength 0.17
    • Paper Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuv… DOI 10.1016/j.pan.2023.10.016↗
11. Masahiro Itonaga · 1 shared paper, 2023 · strength 0.17
    • Paper Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuv… DOI 10.1016/j.pan.2023.10.016↗
12. Takashi Tamura · 1 shared paper, 2023 · strength 0.17
    • Paper Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuv… DOI 10.1016/j.pan.2023.10.016↗
13. Yasunobu Yamashita · 1 shared paper, 2023 · strength 0.17
    • Paper Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuv… DOI 10.1016/j.pan.2023.10.016↗
14. Reiko Ashida · 1 shared paper, 2023 · strength 0.17
    • Paper Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuv… DOI 10.1016/j.pan.2023.10.016↗
15. Masayuki Kitano · 1 shared paper, 2023 · strength 0.17
    • Paper Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuv… DOI 10.1016/j.pan.2023.10.016↗
16. Masahiro Katsuda · 1 shared paper, 2021 · strength 0.15
    • Paper Advances in immunotherapy for pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.944↗
17. Masaji Tani · 1 shared paper, 2014 · strength 0.04
    • Paper Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.109↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.